Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization

Journal of Laboratory and Clinical Medicine

Volumn 147, Issue 6, 2006, Pages 301-309

  Darvill, Angela M ^a   Ballardie, Francis W ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BIOACCUMULATION; BIOASSAY; BLOOD SAMPLING; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MESANGIUM CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCAR FORMATION;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIGENS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EXTRACELLULAR MATRIX PROTEINS; GLOMERULONEPHRITIS, IGA; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MESANGIAL CELLS;

EID: 33646920118     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2006.02.001     Document Type: Article

References (38)

1. Diamond J.R., and Karnovsky M.J. Focal and segmental glomerulosclerosis. analogies to atherosclerosis. Kidney Int 33 (1988) 917-924
2. El Nahas A.M. Pathways to renal fibrosis. Exp Nephrol 3 (1995) 71-75
3. Ortiz A. Apoptotic regulatory proteins in renal injury. Kidney Int 58 (2000) 467-485
4. Hugo C., Hugo C., Pilcher R., Gordon K., Schmidt R., Amieva M., et al. The cytoskeletal linking proteins, moesin and radixin are upregulated by platelet-derived growth factor in experimental mesangial proliferative glomerulonephritis, but not basic fibroblast growth factor. J Clin Invest 97 11 (1996) 2499-2508
5. Striker L.M.-M., Killen P.D., Chi E., and Striker G.E. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 51 (1984) 181-191
6. Stokes M.B., Holler S., Cui Y., Hudkins K.L., Eitner F., Fogo A., and Alpers C.E. Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 57 (2000) 487-498
7. Couser W.G., and Johnson R.J. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23 (1994) 193-198
8. Johnson R.J., Alpers C.E., Yoshimura A., Lombardi D., Pritzl P., Floege J., et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 19 (1992) 464-474
9. Gomez-Garre D., Ruiz-Ortega M., Ortego M., Largo R., Lopez-Armada M.J., Plaza J.J., et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27 (1996) 885-892
10. Hahn S., Krieg R.J., Hisano S., Chan W., Kuemmerle N.B., Saborio P., et al. Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney. Pediatr Nephrol 13 (1999) 195-198
11. Ballardie F.W. Immunoglobulin A-related nephropathies. pathogenesis and treatment. Adv Renal Med 21 (1992) 183-214
12. Ballardie F.W., and Roberts I.S.D. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 13 (2002) 142-148
13. Berger J., and Hinglais N. Les Depots intracapillaires d'IgA-IgG. J Urol 73 (1968) 694-695
14. Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol 18 (2005) 676-680
15. Feltis J.T., Holley K.M., Feiner H., Gallo G., and Ackad A.S. Active and chronic phases of Berger's disease (IgA nephropathy). Am J Kidney Dis 3 5 (1984) 349-356
16. Ballardie F.W., Brenchley P.E.C., Williams S., and O'Donoghue D.J. Autoimmunity in IgA nephropathy. Lancet ii (1988) 588-592
17. O'Donoghue D.J., Darvill A.M., and Ballardie F.W. Mesangial cell autoantigens in IgA nephropathy and Henoch Schonlein purpura. J Clin Invest 88 (1991) 1522-1530
18. Fornasieri A., Pinerolo C., Bernasconi P., Armelloni S., Gibelli A., and D'Amico G. Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy. Clin Nephrol 44 2 (1995) 71-79
19. Darvill A.M., and Ballardie F.W. Human mesangial cell autoantigen of IgA nephropathy. expression in normal and diseased tissue defined by novel monoclonals. J Am Soc Nephrol 5 3 (1994) 828
20. Mene P. Mesangial cell cultures. J Nephrol 14 (2001) 198-203
21. de Caestecker M.P., Bottomley M., Telfer B.A., Hutchinson I.V., Vose B.M., and Ballardie F.W. Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int 44 6 (1993) 1298-1308
22. Ballardie F.W., Gordon M.T., Sharpe P.T., Darvill A.M., and Cheng H. Intrarenal cytokine mRNA expression and location in normal and IgA nephropathy tissue. TGFα, TGFβ, IGF1, IL-4 and IL-6. Nephrol Dial Transpl 9 11 (1994) 1545-1552
23. Julian B.A., Cannon V.R., Waldo F.B., and Egido J. Macroscopic haematuria and proteinuria preceding renal IgA nephropathy. Am J Kidney Dis 17 (1991) 472-479
24. Klein D.J., Brown D.M., Kim Y., and Oegema T. Proteoglycans synthesised by human glomerular mesangial cells in culture. J Biol Chem 265 16 (1990) 9533-9543
25. Groggel G.C., Hovingh P., and Linker A. Proteoglycan and glycosaminoglycan synthesis by cultured rat mesangial cells. J Cell Physiol 147 (1991) 455-459
26. van Det N.F., van den Born J., Tamsma J.T., Verhagen N.A., van den Heuvel L.P., Berd J.H., et al. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J 307 (1995) 759-787
27. Rovin B. Chemokine blockade as a therapy for renal disease. Curr Opin Nephrol Hypert 9 3 (2000) 225-232
28. Negrete H., Studer R.K., Craven P.A., and de Rubertis F.R. Role for transforming growth factor beta in thromboxane induced increases in mesangial cell fibronectin synthesis. Diabetes 44 3 (1995) 335-339
29. Hansch G.M., Wagner C., Burger A., Dong W., Staehler G., and Stoek M. Matrix protein synthesis by glomerular mesangial cells in culture. effects of transforming growth factor beta (TGFβ) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J Cell Physiol 163 3 (1995) 451-457
30. Border W.A., Okuda S., Languino L.R., Sporn M.B., and Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against ransforming growth factor β1. Nature 346 (1990) 371-374
31. Matejtschuk P, ed. Affinity Preparations: A Practical Approach. New York: IRL Press at Oxford University Press; 1997. Protein G Antibody Purification. Proteus Ltd; 2000. Amersham BioSciences FPLC product data sheet; 2001.
32. Radeke H.H., Gessner J.E., Uciechowski P., Magert H.J., Schmidt R.E., and Resch K. Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma- chain. J Immunol 153 3 (1994) 1281-1292
33. Tarzi R.M., Davies K.A., Robson M.G., Fossati-Jimack L., Saito T., Walport M.J., et al. Nephrotoxic nephritis is mediated by Fcγ receptors on circulating leukocytes and not intrinsic renal cells. Kidney Int 62 6 (2002) 2087-2093
34. Harendza S., Schneider A., Helmchen U., and Stahl R.A.K. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol Dial Transpl 14 (1999) 2873-2879
35. Becker G.J., Perkovic V., and Hewitson T.D. Pharmacological intervention in renal fibrosis and vascular sclerosis. J Nephrol 14 (2001) 332-339
36. Gḿez-Guerrero C., Suzuki Y., and Egido J. The identification of IgA receptors in human mesangial cells. in the search for Eldorado. Kidney Int 62 2 (2002) 715-717
37. Laville M., and Almartine E. Treatment options for IgA Nephropathy in adults. a proposal for evidence-based strategy. Nephrol Dial Transpl 19 (2004) 1041-1046
38. Ballardie F.W. IgA Nephropathy 25 years on: can we halt progression? The evidence base. Nephrol Dial Transpl 19 (2004) 1-6